DrugPatentWatch Database Preview
Details for Patent: 6,878,721
» See Plans and Pricing
Which drugs does patent 6,878,721 protect, and when does it expire?
Patent 6,878,721 protects ARCAPTA NEOHALER and UTIBRON and is included in two NDAs.
This patent has forty-nine patent family members in thirty-four countries.
Summary for Patent: 6,878,721
| Title: | Beta2-adrenoceptor agonists |
| Abstract: | Compounds of formula ##STR1## in free or salt or solvate form, where Ar is a group of formula ##STR2## Y is carbon or nitrogen and R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6, R.sup.7, R.sup.8, R.sup.9, R.sup.10, X, n, p, q and r are as defined in the specification, their preparation and their use as pharmaceuticals, particularly for the treatment of obstructive or inflammatory airways diseases. |
| Inventor(s): | Cuenoud; Bernard (Horsham, GB), Bruce; Ian (Horsham, GB), Fairhurst; Robin Alec (Horsham, GB), Beattie; David (Horsham, GB) |
| Assignee: | Novartis AG (Basel, CH) |
| Application Number: | 10/009,008 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 6,878,721 |
|
Patent Claim Types: see list of patent claims | Compound; Composition; Use; Process; |
Drugs Protected by US Patent 6,878,721
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novartis | ARCAPTA NEOHALER | indacaterol maleate | POWDER;INHALATION | 022383-001 | Jul 1, 2011 | DISCN | Yes | No | Start Trial | Start Trial | Y | Y | THE LONG TERM, ONCE-DAILY MAINTENANCE BRONCHODILATOR TREATMENT OF AIRFLOW OBSTRUCTION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), INCLUDING CHRONIC BRONCHITIS AND/OR EMPHYSEMA | Start Trial | ||
| Novartis | UTIBRON | glycopyrrolate; indacaterol maleate | POWDER;INHALATION | 207930-001 | Oct 29, 2015 | DISCN | Yes | No | Start Trial | Start Trial | Y | Y | LONG - TERM MAINTENANCE TREATMENT OF AIRFLOW OBSTRUCTION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) | Start Trial | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 6,878,721
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| United Kingdom | 9913083 | Jun 04, 1999 |
| PCT Information | |||
| PCT Filed | June 02, 2000 | PCT Application Number: | PCT/EP00/05058 |
| PCT Publication Date: | December 14, 2000 | PCT Publication Number: | WO00/75114 |
International Family Members for US Patent 6,878,721
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 035548 | Start Trial | |||
| Austria | 440083 | Start Trial | |||
| Australia | 5074500 | Start Trial | |||
| Australia | 765919 | Start Trial | |||
| Belgium | 2010C011 | Start Trial | |||
| Brazil | 0011324 | Start Trial | |||
| Canada | 2375810 | Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
